A blood test that detects a protein linked to Alzheimer’s disease could help predict whether older adults will develop cognitive decline within five to 10 years, according to a new Mayo Clinic study published in JAMA Neurology.
The study looked at levels of phosphorylated tau 217 (p-tau217) in 2,178 cognitively unimpaired adults, ranging in age from 60 to 90. It also considered age, gender and whether participants carried the APOE ε4 genetic variant , which is associated with Alzheimer’s risk.
The participants – drawn from the Mayo Clinic Study of Aging and the Alzheimer's Disease Neuroimaging Initiative – underwent blood biomarker testing…
Read the full article at FOXNEWS.COM





